Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sarah Christine Hobbs is active.

Publication


Featured researches published by Sarah Christine Hobbs.


Journal of The Chemical Society, Chemical Communications | 1993

The synthesis of (+)- and (–)-epibatidine

Stephen Robert Fletcher; Raymond Baker; Mark Stuart Chambers; Sarah Christine Hobbs; Paul J. Mitchell

The synthesis of the alkaloid epibatidine {exo-2-(2-chloro-5-pyridyl)-7-azabicyclo[2.2.1]heptane} in enantiomeric form involving, as the critical step, reaction or 5-lithio-2-chloropyridine with N-tert-butoxycarbonyl-7-azabicyclo[2.2.1]heptan-2-one is described.


Bioorganic & Medicinal Chemistry Letters | 1993

L-708,474: the C5-cyclohexyl analogue of L-365,260, a selective high affinity ligand for the CCKB/gastrin receptor

Mark Stuart Chambers; Sarah Christine Hobbs; Stephen Robert Fletcher; Victor Giulio Matassa; Paul J. Mitchell; Alan P. Watt; Raymond Baker; Stephen B. Freedman; Smita Patel; Alison J. Smith

Abstract The C5-cyclohexyl analogue of the cholecystokinin type-B (CCKB) receptor antagonist L-365,260 has been prepared. This derivative has significantly higher CCKB affinity and markedly improved CCKB/CCKA receptor selectivity (6,500 v. 87-fold) than the parent compound. It is one of the most potent and selective CCKB ligands reported to date.


Bioorganic & Medicinal Chemistry Letters | 1995

POTENT, SELECTIVE, WATER-SOLUBLE BENZODIAZEPINE-BASED CCKB RECEPTOR ANTAGONISTS THAT CONTAIN LIPOPHILIC CARBOXYLATE SURROGATES

Mark Stuart Chambers; Sarah Christine Hobbs; Michael I. Graham; Alan P. Watt; Stephen Robert Fletcher; Raymond Baker; Stephen B. Freedman; Smita Patel; Alison J. Smith; Victor Giulio Matassa

Abstract Acylsulphonamide analogues of the meta-tolylurea L-708,474 have been synthesised and evaluated as CCKB receptor antagonists. Such derivatives retain very high affinity and subtype selectivity for the CCKB receptor, and have good aqueous solubility. The ortho-tolyl acylsulphonamide L-736,309 is orally bioavailable and brain penetrant in rat.


Journal of Liquid Chromatography & Related Technologies | 1999

ENANTIOMERIC SEPARATION OF A SERIES OF 1,4-BENZODIAZEPIN-2-ONE CCK B RECEPTOR ANTAGONISTS BEARING ACIDIC SUBSTITUENTS BY CHIRAL HPLC

Alan P. Watt; Denise Rathbone; Hugh M. Verrier; Mark Stuart Chambers; Sarah Christine Hobbs

A series of 1,4-benzodiazepin-2-one CCKB receptor antagonists are reported in which substitution at C3 of the benzodiazepine by a phenyl-urea group bearing acidic moieties has generated a chiral centre. As one of these enantiomers is substantially more selective for the CCKB over the CCKA receptor, an analytical separation of the enantiomers was developed to monitor the resolution of compounds by chemical means. It was shown that such compounds may be resolved using a Pirkle-type 3,5-dinitrobenzoyl-leucine chiral stationary phase to give high α and RS values. However, traditional mobile phase methodologies proved unsuccessful with these compounds which were found not to elute without the addition of acetic acid. An investigation is described in which the effect of the acidic substituent, mobile phase composition, including addition of acid, and temperature is discussed for such compounds.


Journal of Organic Chemistry | 1994

Total Synthesis and Determination of the Absolute Configuration of Epibatidine

Stephen Robert Fletcher; Raymond Baker; Mark Stuart Chambers; Richard H. Herbert; Sarah Christine Hobbs; Steven R. Thomas; Hugh M. Verrier; Alan P. Watt; Richard G. Ball


Archive | 1996

Azetidine, pyrrolidine and piperidine derivatives

Raymond Baker; Sylvie Bourrain; Jose Luis Castro Pineiro; Mark Stuart Chambers; Alexander Richard Guiblin; Sarah Christine Hobbs; Richard Alexander Jelley; Andrew Madin; Victor Giulio Matassa; Austin John Reeve; Michael Geoffrey Neil Russell; Graham A. Showell; Francine Sternfeld; Leslie J. Street; Monique Bodil Van Niel


Archive | 1995

Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists

Pineiro Jose Luis Castro; Mark Stuart Chambers; Sarah Christine Hobbs; Victor Giulio Matassa; Austin John Reeve; Graham A. Showell; Leslie J. Street


Bioorganic & Medicinal Chemistry Letters | 2006

Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction

Philip Jones; John R. Atack; Matthew P. Braun; Brian P. Cato; Mark Stuart Chambers; Desmond O’Connor; Susan M. Cook; Sarah Christine Hobbs; Robert James Maxey; Helen Jane Szekeres; Nicola Szeto; Keith A. Wafford; Angus Murray Macleod


Archive | 1996

Piperidine and tetrahydropyridine derivatives

Mark Stuart Chambers; Sarah Christine Hobbs; Tamara Ladduwahetty; Angus Murray Macleod; Kevin John Merchant


Archive | 1997

Thienycyclohexanone derivatives as ligands of the GABAA α5 receptor subtype

Howard B. Broughton; Mark Stewart Chambers; Sarah Christine Hobbs; Angus Murray Macleod; Austin John Reeve

Collaboration


Dive into the Sarah Christine Hobbs's collaboration.

Researchain Logo
Decentralizing Knowledge